FedEx Blog

FedEx Blog

Latest Posts by Christelle Laot

January 7, 2015

Struggling to comply with DSCSA for prescription drugs? FedEx TranSmart® can help!

Many regulations and initiatives worldwide aim at further securing and controlling the complex supply chain of healthcare shipments. The US Drug Supply Chain Security Act (DSCSA), also known as Title II of the Drug Quality and Security Act (DQSA), was signed into law on November 27th, 2013. It represents a staggered approach towards serialization, and electronic track-and-trace for human prescription drugs in finished dosage form.

November 25, 2014

Measuring Up When it Comes to Temperature-Controlled Transportation

Performance measurements in the form of metrics or key performance indicators help companies in streamlining operations and improving the bottom line. When logistics metrics are shared externally among stakeholders, for instance between healthcare shippers and transportation providers, this may lead to an improvement in the supply chain and a better customer experience overall. Were your shipments delayed? You can find out why by accessing reports and having regular discussions. Transportation providers have established general metrics to report shipping performance.

August 12, 2014

Mode Shift in Freight Transportation

Have you ever heard of “mode shift” in the shipping context? It refers to the change in the type of transportation used to move your shipments around. Mode shift is a trend that is often on the agenda at transportation conferences as many shippers choose ocean freight forwarding rather than air cargo freight for intercontinental

June 2, 2014

Validation versus Qualification in Shipping

Many healthcare shippers ask us at FedEx Express whether our cold chain transportation solutions are validated.

February 13, 2014

Flowers or Chocolate – Quantifying Business Value

As we get close to Valentine’s Day, many of you may be wondering what to buy for your loved ones: flowers or chocolate?

January 8, 2014

Risky Business

This year the Food and Drug Administration (FDA) issued a report titled “Pharmaceutical cGMPs for the 21st Century: A Risk-Based Approach” (cGMP stands for Current Good Manufacturing Practices). The Medicines and Healthcare products Regulatory Agency (MHRA), the equivalent of the FDA in the United Kingdom, has long adopted a risk-based inspection strategy. A risk corresponds to the possibility that a function, a procedure or a product does not perform as expected. Risk management programs consist of activities and actions to control risks.